產品資訊 - Flunixin Meglumine Veterinary Injection->Food Additive

登入

加入會員

求助

HEBEI PENGFU TRADING CO., LTD

	Recommended Results

Flunixin Meglumine Veterinary Injection

產品分類 :

化學->化學原料->食物附加劑

產品規格

Country	CN
Payment Term	L/C,T/T,Western Union

產品描述

Flunixin Meglumine Veterinary Injection;Flunixin Meglumine Veterinary Drug of Injection;Prevetn Veterinary Disease


Flunixin Meglumine Veterinary Drug Injection

<div style="margin:0px;padding:0px;border:0px;font-family:Arial, Helvetica;vertical-align:baseline;color:#333333;">
Product Uses: 
Flunixin meglumine is a relatively potent non-narcotic, non-steroidal analgesic with anti-inflammatory and anti-pyretic properties. In the horse, Flunixin Injection is indicated for the alleviation of inflammation and pain associated with musculo-skeletal disorders especially in acute and chronic stages and for the alleviation of visceral pain associated with colic. In cattle, Flunixin Injection is indicated for the control of acute inflammation associated with respiratory disease. Veterinary Antibiotic Medicine 
Dosage Admin: 
Flunixin Injection is indicated for intravenous administration to cattle and horses. HORSES: For use in equine colic, the recommended dose rate is 1.1 mg flunixin/kg bodyweight equivalent to 1 ml per 45 kg bodyweight by intravenous injection. Treatment may be repeated once or twice if colic recurs. For use in musculo-skeletal disorders, the recommended dose rate is 1.1 mg flunixin/kg bodyweight, equivalent to 1 ml per 45 kg bodyweight injected intravenously once daily for up to 5 days according to clinical response. CATTLE: The recommended dose rate is 2.2 mg flunixin/kg bodyweight equivalent to 2 ml per 45 kg bodyweight injected intravenously and repeated as necessary at 24 hour intervals for up to 3 consecutive days.
</div>

 
Contra Indications: 
Do not administer to pregnant animals. Monitor drug compatibility closely where adjunctive therapy is required. Avoid intra-arterial injection. It is preferable that NSAIDs, which inhibit prostaglandin synthesis, are not administered to animals undergoing general anaesthesia until fully recovered. Horses intended for racing and competition should be treated according to local requirements and appropriate precautions must be taken to ensure compliance with the competition regulations. In case of doubt it is advisable to test the urine. The cause of the underlying inflammatory condition or colic should be determined and treated with appropriate concomitant therapy.Use is contra-indicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product. Do not administer other non-steroidal anti-inflammatory drugs (NSAIDs) concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects. Use in any animal less than 6 weeks of age or in aged animals may involve an additional risk. If such use cannot be avoided animals may require a reduced dosage and careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. Concurrent administration of potentially nephrotoxic drugs should be avoided. In case of spillage onto skin wash immediately with water. To avoid possible sensitisation reactions, avoid contact with the skin. Gloves should be worn during application. The product may cause reactions in sensitive individuals. If you have known hypersensitivity for non-steriodal anti-inflammatory products do not handle the product. Reactions may be serious.  
Withdrawal Periods: 
Cattle may be slaughtered for human consumption only after 14 days from the last treatment. Horses may be slaughtered for human consumption only after 28 days from the last treatment. Milk for human consumption must not be taken during treatment. Milk for human consumption may only be taken from treated cows after 2 days from the last treatment.  
Pharmaceutical Precautions:


Do not store above 25¦C. Protect from light. Store out of reach of children. Avoid introduction of contamination. Following withdrawal of the first dose, use the product within 28 days. Discard unused product. At the first time of use, insert the date to discard the product on the label. ML: 2000/01


<img src="http://i.bosscdn.com/product/5c/44/fb/c8acaaebd05c0f22a62e31210f.jpg" title="Flunixin Meglumine Injection" alt="Flunixin Meglumine Injection" /> 



 
pengfu-trading.com

其他類似產品